Atlas Trials

Effect of Androgel on Atherogenesis in Type 2 Diabetic Males With Hypogonadotrophic Hypogonadism

Clinical trial NCT00467987 · TERMINATED

Trial details

NCT number
NCT00467987
Sponsor
University at Buffalo
Status
TERMINATED
Phase
Not Applicable
Study type
INTERVENTIONAL
Type 2 Diabetic Male With Hypogonadotrophic Hypogonadism
Start date
2007-06-01
Primary completion
2018-03-01
Enrollment
47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.